tetano
Editor, Senior Moderator
SN Compr Clin Med
. 2020 Oct 17;1-4.
doi: 10.1007/s42399-020-00601-9. Online ahead of print.
Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Gu?rin (BCG): Case Report
Michelangelo Luciani[SUP] 1 [/SUP], Enrico Bentivegna[SUP] 1 [/SUP], Valerio Spuntarelli[SUP] 2 [/SUP], Piera Amoriello Lamberti[SUP] 1 [/SUP], Ludovica Guerritore[SUP] 1 [/SUP], Dario Chiappino[SUP] 1 [/SUP], Gabriele Nalli[SUP] 1 [/SUP], Maria Proietta[SUP] 1 [/SUP], Flavia Del Porto[SUP] 1 [/SUP], Paolo Martelletti[SUP] #[/SUP][SUP] 2 [/SUP], Giorgio Sesti[SUP] #[/SUP][SUP] 1 [/SUP]
Affiliations
Abstract
COVID-19 is a respiratory tract infection caused by the new coronavirus SARS-COV2 that can be complicated by acute distress respiratory syndrome and multiorgan failure. In light of the high rate of mortality associated with COVID-19, pharmacological and non-pharmacological strategies to prevent the infection are currently being tested. Among non-pharmacological preventive measures, vaccines represent one of the main resources for public health. It has been suggested that Bacille Calmette-Gu?rin (BCG) vaccine may protect individuals against infection from COVID-19 virus, and two clinical trials addressing this question are underway. Here, we report the case of a 32-year-old woman, vaccinated with BCG when she was 1 year old, who was diagnosed with apical tuberculous pneumonia of the right lung along with COVID 19 pneumonia.
Keywords: BCG; Covid-19; Immunity; Pneumonia; SARS-CoV-2; Tuberculosis.
. 2020 Oct 17;1-4.
doi: 10.1007/s42399-020-00601-9. Online ahead of print.
Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Gu?rin (BCG): Case Report
Michelangelo Luciani[SUP] 1 [/SUP], Enrico Bentivegna[SUP] 1 [/SUP], Valerio Spuntarelli[SUP] 2 [/SUP], Piera Amoriello Lamberti[SUP] 1 [/SUP], Ludovica Guerritore[SUP] 1 [/SUP], Dario Chiappino[SUP] 1 [/SUP], Gabriele Nalli[SUP] 1 [/SUP], Maria Proietta[SUP] 1 [/SUP], Flavia Del Porto[SUP] 1 [/SUP], Paolo Martelletti[SUP] #[/SUP][SUP] 2 [/SUP], Giorgio Sesti[SUP] #[/SUP][SUP] 1 [/SUP]
Affiliations
- PMID: 33103062
- PMCID: PMC7568690
- DOI: 10.1007/s42399-020-00601-9
Abstract
COVID-19 is a respiratory tract infection caused by the new coronavirus SARS-COV2 that can be complicated by acute distress respiratory syndrome and multiorgan failure. In light of the high rate of mortality associated with COVID-19, pharmacological and non-pharmacological strategies to prevent the infection are currently being tested. Among non-pharmacological preventive measures, vaccines represent one of the main resources for public health. It has been suggested that Bacille Calmette-Gu?rin (BCG) vaccine may protect individuals against infection from COVID-19 virus, and two clinical trials addressing this question are underway. Here, we report the case of a 32-year-old woman, vaccinated with BCG when she was 1 year old, who was diagnosed with apical tuberculous pneumonia of the right lung along with COVID 19 pneumonia.
Keywords: BCG; Covid-19; Immunity; Pneumonia; SARS-CoV-2; Tuberculosis.